跳至主要内容
临床试验/NCT05464849
NCT05464849
已完成
不适用

Evaluation of Systemic Microvascular Reactivity in Patients With Resistant Hypertension

National Institute of Cardiology, Laranjeiras, Brazil2 个研究点 分布在 1 个国家目标入组 111 人2021年12月20日

概览

阶段
不适用
干预措施
Evaluation of systemic skin microvascular endothelial function
疾病 / 适应症
Arterial Hypertension
发起方
National Institute of Cardiology, Laranjeiras, Brazil
入组人数
111
试验地点
2
主要终点
Systemic microvascular reactivity
状态
已完成
最后更新
19天前

概览

简要总结

Systemic arterial hypertension is a serious health problem worldwide. In some cases, it can phenotypically present as resistant arterial hypertension, which consists of blood pressure levels outside the treatment goals in patients using three or more classes of antihypertensive drugs, one of which is preferably a thiazide diuretic. Resistant hypertension contributes to a 47% higher risk of developing cardiovascular events when compared to patients with non-resistant hypertension. It is known that the microcirculation plays a relevant role in the pathophysiology of arterial hypertension. Furthermore, it is known that the cutaneous microvascular network is an adequate model and that it reflects the systemic microcirculation. In this sense, the present research proposes the study of cutaneous capillary density - through high resolution intravital microscopy - and of the endothelium-dependent and independent microvascular vasodilator response - by the speckle laser flowmetry method coupled to a pharmacological system of micro- iontophoresis - in patients diagnosed with resistant hypertension, with the aim of identifying changes in comparison with patients with non-resistant hypertension and normotensive individuals. Additionally, the evaluation of the association between systemic microvascular function and the presence of target organ lesions in this population may indicate that this is a new non-invasive way of stratifying cardiovascular risk in these individuals.

注册库
clinicaltrials.gov
开始日期
2021年12月20日
结束日期
2025年12月30日
最后更新
19天前
研究类型
Observational
性别
All

研究者

发起方
National Institute of Cardiology, Laranjeiras, Brazil
责任方
Principal Investigator
主要研究者

Eduardo Tibirica, MD, PhD

Senior researcher

National Institute of Cardiology, Laranjeiras, Brazil

入排标准

入选标准

  • Resistant hypertension

排除标准

  • Pregnancy or lactation for all groups.
  • For the control group: endocrine and metabolic diseases, including diabetes mellitus, cardiovascular diseases, including hypertension, autoimmune diseases and cancer.
  • For the resistant arterial hypertension and non-resistant arterial hypertension groups: endocrine diseases, except diabetes mellitus, autoimmune diseases and cancer .

研究组 & 干预措施

normotensive subjects

control group including normotensive volunteers

干预措施: Evaluation of systemic skin microvascular endothelial function

Resistant hypertension

Patients presenting with resistant hypertension

干预措施: Evaluation of systemic skin microvascular endothelial function

non-resistant hypertension

Patients presenting with non-resistant hypertension

干预措施: Evaluation of systemic skin microvascular endothelial function

结局指标

主要结局

Systemic microvascular reactivity

时间窗: two years - during one visit to the microcirculation laboratory

evaluation of endothelium-dependent and -independent microvascular function

研究点 (2)

Loading locations...

相似试验